A series of 2-amino-4H-pyran-3-carbonitrile derivatives were designed and synthesized. Their antitubercular activities were evaluated against autoluminescent M. tuberculosis H37Ra and standard strain M. tuberculosis H37Rv. No obvious antitubercular activities could be observed (MIC > 10 g/mL). The results are in sharp contrast with the previously reported data.
Introduction
Tuberculosis (TB) is a chronic disease caused by Mycobacterium tuberculosis. It continues to be a serious threat for human health [1, 2] . Every year about two million people die of this disease and almost eight million people get tuberculosis. The present antitubercular treatment typically requires the combination of at least two first-line drugs (rifampicin, isoniazid, ethambutol and pyrazinaimde) for an extended period (6 -12 months). The poor compliance to the rigid implementation of therapy leads to the emergence of multi-drug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis, which have brought new challenges for clinical treatment [3] [4] [5] [6] . In addition, the rising incidence of TB and HIV co-infection makes the treatment more difficult.
The development of antitubercular agents with new action mechanism is an urgent task [7, 8] . In recent ten years, a number of candidates have appeared with promising activities against sensitive and resistant Mycobacterium tuberculosis strains. In 2007, Perumal and coworkers reported 2-aminopyranopyridine-3-carbonitriles as a new type of antitubercular agents (Scheme 1) [9] . Several compounds showed excellent antitubercular activity comparable with isoniazid. Recently Perumal, Sriram and co-workers also found that 1,2,4-oxadiazoles derived from 2-aminopyranopyridine-3-carbonitriles showed enhanced antitubercular activity (Scheme 1) [10] . These results strongly suggest that 2-amino-4H-pyran-3-carbonitrile is a new pharmacophore of antitubercular agents.
Recently we have developed efficient methods for the synthesis of homochiral 2-amino-4H-pyran-3-carbonitriles [11, 12] . We are interested in the effect of chiral center of these compounds on the antitubercular activity. We are also interested in the further improvement of the antitubercular activity of 2-amino-4H-pyran-3-carbonitriles by structural modifications. In this paper, we report the synthesis of racemic and homochiral 2-amino-pyranopyridine-3-carbonitriles as well as their structural analogs. The antitubercular activity was evaluated in vitro against autoluminescent Mycobacterium tuberculosis H37Ra and standard strain Mycobacterium tuberculosis H37Rv.
C. X. CHEN ET AL.
Open Access OJMC 
Results and Discussion

Chemistry
Racemic 2-aminopyranopyridine-3-carbonitriles 2a-2g were prepared from dienones 1a-1g and malononitrile in the presence of piperidine. Generally excellent yields (92% -99%) were obtained (Scheme 2).
To explore the effect of chiral centers in 2a-2g, homochiral (S)-2a, (S)-2d, (R)-2a, and (R)-2d were prepared. Excellent yields and enantioselectivities were achieved using chiral thiourea-tertiary amines 3a and 3b as the catalysts (Scheme 3) [11] .
2-Aminopyranopyridine-3-carbonitriles 2h-2n derived from monoenones 1h-1n were also prepared (Scheme 4) [12] . Cyclic enones 1h-1j reacted with malononitrile in the presence of triethylamine. The reaction of acyclic enones 1k-1n was achieved using piperidine as the catalyst. Generally products 2h-2n were obtained in good yields.
For a further understanding the effect of C (sp 3 ) chiral structure in 2-aminopyranopyridine-3-carbonitriles, the compounds 4a and 4j with achiral pyridine structure were designed. The treatment of 2-amino-pyran 2a and 2j with ammonium acetate provided 4a and 4j in good yields (Scheme 5) [13] .
Evaluation of Antitubercular Activity
The antitubercular activity of racemic 2-amino-4H-pyran-3-carbonitriles 2a-2e, homochiral 2-amino-4H-pyran-3-carbonitriles (S)-2a, (S)-2d, (R)-2a, and (R)-2d were evaluated against autoluminescent M. tuberculosis H37Ra [14] . This screen model is fast and cost-efficient for the preliminary evaluation of antitubercular activity. Isoniazid and rifampicin were used as the positive control and the results are listed in Figure 1 . The bacteria growth was conveniently monitored by the bioluminescence intensity. Unexpectedly all compounds including 2a and 2d did not showed obvious antitubercualr activity.
We further examined the inhibitive activity of the compounds against standard strain M. tuberculosis H37Rv and the results are summarized in Table 1 . Perumal and co-workers reported that compound 2a and 2d possess excellent antitubercular activities (MIC 0.97 and 0.92 g/mL against H37Rv respectively) [9] . Our present study led to significantly different results. Racemic 2a, 2d and their homochiral enantiomers did not show obvious antitubercular activities (MIC > 10 g/mL). Other structural analogs 2b, 2c, 2e-2g also appeared to be inefficient. The compounds 2h-2n and 4a, 4j with further structural diversities still showed disappointed antitubercular activities. These results brought the question about the reported antitubercular activity of 2-amino-4H-pyran-3-carbonitriles by Perumal and co-workers. Although a clear conclusion could not be achieved so far, the further examination of the reported data is highly desirable.
Conclusion
In conclusion, we designed and synthesized a series of 2-amino-4H-pyran-3-carbonitriles and their structural analogs. Homochiral 2-amino-4H-pyran-3-carbonitriles were also prepared via the organocatalytic enantioselctive reaction. The antitubercualr activities of these compounds were determined against autoluminescent M. tuberculosis H37Ra and standard strain M. tuberculosis H37Rv, however, no obvious inhibitive activities could be observed. The results are in sharp contrast with the previously reported data. Before the further attempt to develop 2-amino-4H-pyran-3-carbonitriles as potential antitubercular agents, the clarification of the contradictive activity data is required. ried out over silica gel (230 -400 mesh), purchased from Qingdao Haiyang Chemical Co. Ltd. Melting points were recorded on an electrothermal digital melting point apparatus and were uncorrected. TLC analysis was performed on precoated silica gel GF254 slides, and visualised by either UV irradiation. Unless otherwise stated, all reagents were obtained from commercial sources and used as received. The solvents were used as commercial anhydrous grade without further purification. Enantiomeric excesses were determined by HPLC using a Daicel Chiralpak AD-H column (4.6 mm × 25 cm) and eluting with hexane/2-PrOH solution. 
Experimentals
Typical Procedure for the Synthesis of Compounds 2a-2g
A mixture of (3E, 
(E)-2-Amino-8-(4-Chlorobenzylidene)-4-(4-Chlorophe-nyl)-6-Methyl
(E)2-Amino-8-(4-Fluorobenzylidene)-4-(4-
(E)-2-Amino-8-(4-Fluorobenzylidene)-4-(4-
Typical Procedure for the Synthesis of Homochiral Compounds (S)-2a, (S)-2d, (R)-2a, and (R)-2d
A mixture of (3E, 5E)-3,5-bis(4-fluorobenzylidene)-1-methylpiperidin-4-one 1a (66.1 mg, 0.2 mmol), malononitrile (19.8 mg, 0.3 mmol) and 3a (9.0 mg, 0.02 mmol) in toluene (2 mL) were stirred for 28 h at room temperature. The white precipitate (S)-2a was collected by the centrifugalization. 1. 2-Amino-4-(4-Fluorophenyl) Fluorophenyl) 
(S,E)-2-Amino-8-(4-
Fluorobenzylidene
2-Amino-4-(4-
Typical Procedure for the Synthesis of Compounds 2k-2n
A mixture of (E)-2-benzoyl-3-(4-fluorophenyl)acryloni- 
Typical Procedure for the Synthesis of Compounds 4a and 4j
A mixture of compound 2a (39.1 mg, 0.1 mmol), Ac-ONH 4 (92 mg, 1.2 mmol), and AcOH (1.0 mL) in EtOAc (1.0 mL) was refluxed for 24 h. After cooled to room temperature, EtOAc (10 mL) was added. The mixture was washed with saturated aqueous NaHCO 3 (10 mL) and brine (5 mL), and dried over anhydrous Na 2 SO 4 . After the solvent was evaporated under vacuum, the residue was purified by flash column chromatography (ethyl acetate/petroleum ether = 2:5) to give the products 4a. 
Evaluation of Antitubercular Activity
Autoluminescent M. tuberculosis H37Ra was constructed as previously reported [14] and was inoculated in a 50 mL centrifuge tube containing 5 mL 7H9 with 0.1% Tween80 and 10% ODAC, then incubated at 37˚C with shaking. When the culture reached an OD 600 nm of 0.7, the culture was diluted. 50 L diluted H37Ra were inoculated in sterile 384 well plate. The RLU of each well should be between 8000 -12000 and was recorded as the basic luminescence of Day 0. The test compounds and the positive drugs were added to the 384 well plate in triplicate by the Echo520 with the final concentration 1 or 10 g/mL. The luminescent values were detected for the following three days. The data were analyzed with the Excel compared to the DMSO control to estimate the inhibition activity of the compounds.
The antitubercular activities against M. tuberculosis H37Rv were determined by standard agar dilution method [15] .
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